Kyle E Rusthoven

Summary

Affiliation: University of Colorado Health Sciences Center
Country: USA

Publications

  1. doi request reprint Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach
    Kyle E Rusthoven
    Department of Radiation Oncology, University of Colorado Health Sciences Center, Denver, Colorado 80045 0508, USA
    Int J Radiat Oncol Biol Phys 74:1365-70. 2009
  2. doi request reprint Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis
    Kyle E Rusthoven
    Department of Radiation Oncology, University of Colorado Comprehensive Cancer Center, Denver, USA
    Acta Oncol 48:578-83. 2009
  3. doi request reprint Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme
    Changhu Chen
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045, USA
    Int J Radiat Oncol Biol Phys 81:1066-74. 2011
  4. doi request reprint Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis
    Ari Ballonoff
    Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, CO, USA
    Int J Radiat Oncol Biol Phys 72:1465-71. 2008
  5. doi request reprint Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer
    Kyle E Rusthoven
    University of Colorado Comprehensive Cancer Center, Aurora, CO 80045 0508, USA
    Int J Radiat Oncol Biol Phys 78:1020-5. 2010
  6. doi request reprint Survival and patterns of relapse in patients with oral tongue cancer
    Kyle E Rusthoven
    Department of Radiation Oncology, University of Colorado Denver, Aurora, CO 80045 0508, USA
    J Oral Maxillofac Surg 68:584-9. 2010
  7. doi request reprint Phase I trial of bortezomib and concurrent external beam radiation in patients with advanced solid malignancies
    Thomas J Pugh
    Department of Radiation Oncology, University of Colorado Denver and Health Science Center, Aurora, USA
    Int J Radiat Oncol Biol Phys 78:521-6. 2010
  8. doi request reprint Cardiac mortality in patients with stage I and II diffuse large B-cell lymphoma treated with and without radiation: a surveillance, epidemiology, and end-results analysis
    Thomas J Pugh
    Department of Radiation Oncology, University of Colorado Comprehensive Cancer Center, Colorado, USA
    Int J Radiat Oncol Biol Phys 76:845-9. 2010
  9. doi request reprint Favorable prognosis in patients with high-grade glioma with radiation necrosis: the University of Colorado reoperation series
    Kyle E Rusthoven
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045 0508, USA
    Int J Radiat Oncol Biol Phys 81:211-7. 2011
  10. doi request reprint Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases
    Kyle E Rusthoven
    University of Colorado Denver, Department of Radiation Oncology, Pathology, and Medical Oncology, Aurora, CO 80045, USA
    J Clin Oncol 27:1572-8. 2009

Detail Information

Publications18

  1. doi request reprint Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach
    Kyle E Rusthoven
    Department of Radiation Oncology, University of Colorado Health Sciences Center, Denver, Colorado 80045 0508, USA
    Int J Radiat Oncol Biol Phys 74:1365-70. 2009
    ..To review the outcomes of a prospective management approach using ipsilateral neck radiotherapy in the treatment of node-positive squamous cell carcinoma of the tonsil with a well-lateralized primary lesion...
  2. doi request reprint Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis
    Kyle E Rusthoven
    Department of Radiation Oncology, University of Colorado Comprehensive Cancer Center, Denver, USA
    Acta Oncol 48:578-83. 2009
    ..We evaluate the POF in this setting to estimate the potential value of consolidative stereotactic body radiation therapy (SBRT)...
  3. doi request reprint Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme
    Changhu Chen
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045, USA
    Int J Radiat Oncol Biol Phys 81:1066-74. 2011
    ..To determine the maximal tolerated biologic dose intensification of radiotherapy using fractional dose escalation with temozolomide (TMZ) chemotherapy in patients with newly diagnosed glioblastoma multiforme...
  4. doi request reprint Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis
    Ari Ballonoff
    Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, CO, USA
    Int J Radiat Oncol Biol Phys 72:1465-71. 2008
    ..To assess disease-specific survival (DSS), overall survival (OS), and the effect of radiotherapy (RT) in patients with localized diffuse large B-cell lymphoma (DLBCL)...
  5. doi request reprint Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer
    Kyle E Rusthoven
    University of Colorado Comprehensive Cancer Center, Aurora, CO 80045 0508, USA
    Int J Radiat Oncol Biol Phys 78:1020-5. 2010
    ..To present the first report of a Phase I trial evaluating concurrent and maintenance erlotinib and reirradiation in patients with recurrent or secondary primary head-and-neck cancer (HNC)...
  6. doi request reprint Survival and patterns of relapse in patients with oral tongue cancer
    Kyle E Rusthoven
    Department of Radiation Oncology, University of Colorado Denver, Aurora, CO 80045 0508, USA
    J Oral Maxillofac Surg 68:584-9. 2010
    ..To evaluate the survival and patterns of relapse for patients with squamous cell carcinoma (SCC) of the oral tongue...
  7. doi request reprint Phase I trial of bortezomib and concurrent external beam radiation in patients with advanced solid malignancies
    Thomas J Pugh
    Department of Radiation Oncology, University of Colorado Denver and Health Science Center, Aurora, USA
    Int J Radiat Oncol Biol Phys 78:521-6. 2010
    ..To determine the maximal tolerated dose of bortezomib with concurrent external beam radiation therapy in patients with incurable solid malignant tumors requiring palliative therapy...
  8. doi request reprint Cardiac mortality in patients with stage I and II diffuse large B-cell lymphoma treated with and without radiation: a surveillance, epidemiology, and end-results analysis
    Thomas J Pugh
    Department of Radiation Oncology, University of Colorado Comprehensive Cancer Center, Colorado, USA
    Int J Radiat Oncol Biol Phys 76:845-9. 2010
    ..We hypothesize that patients treated without RT, i.e., those who are treated with greater total chemotherapy cycles and hence cumulative anthracycline exposure, are at increased risk of cardiac mortality...
  9. doi request reprint Favorable prognosis in patients with high-grade glioma with radiation necrosis: the University of Colorado reoperation series
    Kyle E Rusthoven
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045 0508, USA
    Int J Radiat Oncol Biol Phys 81:211-7. 2011
    ..To analyze the pathology, outcomes, and prognostic factors in patients with high-grade glioma undergoing reoperation after radiotherapy (RT)...
  10. doi request reprint Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases
    Kyle E Rusthoven
    University of Colorado Denver, Department of Radiation Oncology, Pathology, and Medical Oncology, Aurora, CO 80045, USA
    J Clin Oncol 27:1572-8. 2009
    ..To evaluate the efficacy and tolerability of high-dose stereotactic body radiation therapy (SBRT) for the treatment of patients with one to three hepatic metastases...
  11. doi request reprint Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapy
    Adam Raben
    Department of Radiation Oncology, Helen F Graham Cancer Center, Wilmington, DE, USA
    Brachytherapy 8:297-303. 2009
    ..The clinical implications of these improvements in dosimetry are unclear. We review toxicity and early biochemical outcomes for patients implanted using IO technique...
  12. doi request reprint Improved survival in patients with Stage III-IV Head and neck cancer treated with radiotherapy as primary local treatment modality
    Kyle E Rusthoven
    Department of Radiation Oncology, University of Colorado Denver, Aurora, CO 80045, USA
    Int J Radiat Oncol Biol Phys 72:343-50. 2008
    ..To evaluate the overall and cause-specific survival in patients with Stage III-IVb head and neck squamous cell carcinoma treated with radiotherapy (RT) as the primary local treatment modality...
  13. doi request reprint Effect of radiation techniques in treatment of oropharynx cancer
    Kyle E Rusthoven
    Department of Radiation Oncology, University of Colorado Denver, Aurora, Colorado 80045 0508, USA
    Laryngoscope 118:635-9. 2008
    ....
  14. ncbi request reprint The role of PET-CT fusion in head and neck cancer
    Kyle E Rusthoven
    Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia 30322, USA
    Oncology (Williston Park) 19:241-6; dicussion 246, 249-50, 253. 2005
    ..PET-CT may also help in target volume delineation during radiotherapy (RT) treatment planning. Better characterization of the target may improve local control as well as spare normal tissues from RT sequelae...
  15. doi request reprint Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer
    Robert McCammon
    Department of Radiation Oncology, University of Colorado Denver, Aurora, CO 80045 0508, USA
    Int J Radiat Oncol Biol Phys 75:413-20. 2009
    ..To evaluate the toxicity of pelvic intensity-modulated radiotherapy (IMRT) with hypofractionated simultaneous integrated boost (SIB) to the prostate for patients with intermediate- to high-risk prostate cancer...
  16. doi request reprint High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trials
    Kyle E Rusthoven
    Department of Radiation Oncology, University of Colorado at Denver and Health Sciences Center, Aurora, CO 80045 0508, USA
    Clin Lung Cancer 9:106-11. 2008
    ..Because patients with early-stage bladder transitional cell carcinoma (TCC) often have a long survival, we considered whether they would constitute a suitable population for a screening study...
  17. ncbi request reprint Accelerated partial-breast intensity-modulated radiotherapy results in improved dose distribution when compared with three-dimensional treatment-planning techniques
    Kyle E Rusthoven
    Department of Radiation Oncology, University of Colorado Health Sciences Center, Denver, CO, USA
    Int J Radiat Oncol Biol Phys 70:296-302. 2008
    ..To compare dose distribution and normal tissue sparing in partial-breast treatment using three-dimensional conformal radiotherapy (3D-CRT) vs. intensity-modulated radiotherapy (IMRT)...
  18. ncbi request reprint The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor
    Kyle E Rusthoven
    Department of Radiation Oncology, Emory Clinic Emory University, Atlanta, Georgia, USA
    Cancer 101:2641-9. 2004
    ..The authors performed a comprehensive review of the efficacy of fluorodeoxyglucose positron emission tomography (FDG-PET) in the detection of primary tumors in patients with cervical metastases from unknown primary tumors...